The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Single-Cell Analysis Transcriptomics Market During 2026–2030?
The single-cell analysis transcriptomics market size has experienced rapid growth in recent years. This market is projected to expand from $1.08 billion in 2025 to $1.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.3%. Factors contributing to its historical growth include the elevated cost of early sequencing equipment, limited accessibility of microfluidics technologies, reliance on conventional bulk tissue analysis, growing academic research funding, and an emerging awareness of cellular heterogeneity.
The single-cell analysis transcriptomics market is projected to experience substantial expansion over the upcoming years. It is forecast to reach $1.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.2%. This anticipated growth during the forecast period can be ascribed to several factors, such as technological progress in single-cell sequencing platforms, the incorporation of cloud-based bioinformatics solutions, heightened investment by pharmaceutical and biotechnology enterprises, expanded adoption in personalized medicine, and the proliferation of hospital and diagnostic center applications. Significant trends for the forecast duration also involve the increasing embrace of single-cell RNA sequencing techniques, the growing utilization of microfluidics-based platforms, the broadening of clinical diagnostics applications, an uptick in drug discovery and development research, and improved data analysis and bioinformatics capabilities.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24400&type=smp
What Underlying Factors Are Accelerating The Growth Of The Single-Cell Analysis Transcriptomics Market?
The increasing integration of personalized medicine is projected to stimulate the growth of the single-cell analysis transcriptomics market in the foreseeable future. Personalized medicine defines a healthcare strategy that customizes treatments based on an individual’s unique genetic makeup, lifestyle choices, and environmental influences. This rising acceptance of personalized medicine is driven by advancements in genetic sequencing technology, which enable the creation of treatments precisely tailored to individual genetic profiles for improved efficacy. Single-cell analysis transcriptomics contributes significantly by uncovering individual gene expression patterns, thereby guiding personalized therapeutic approaches informed by a patient’s specific biology. This capability leads to enhanced therapeutic effectiveness, reduced side effects, and facilitates the early detection of diseases. For example, in February 2024, data from the Personalized Medicine Coalition showed that the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, a notable increase from 6 approvals in 2022. Therefore, the expanding adoption of personalized medicine serves as a key driver for the single-cell analysis transcriptomics market’s expansion.
How Are The Various Segments Of The Single-Cell Analysis Transcriptomics Market Categorized?
The single-cell analysis transcriptomics market covered in this report is segmented –
1) By Component: Equipment, Consumables, Software And Services
2) By Technology: Single-Cell Ribonucleic Acid (RNA) Sequencing, Microfluidics-Based Techniques, Other Technologies
3) By Application: Clinical Diagonstics, Developmental Biology, Drug Discovery, Other Applications
4) By End-User: Academic And Research Institutions, Hospitals And Diagonstic Centers, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Equipment: Ribonucleic Acid (RNA) Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Flow Cytometers, Imaging Systems
2) By Consumables: Reagents And Kits, Ribonucleic Acid (RNA) Extraction Kits, Microarray Chips, Sequencing Chips, Complementary DNA (cDNA) Synthesis Kits, Library Preparation Kits, Enzymes And Buffers
3) By Software And Services: Data Analysis Software, Transcriptome Assembly Software, Cloud-Based Solutions, Bioinformatics Services, Data Management Tools, Custom Analysis Services, Technical Support And Training
What Trends Are Affecting The Expansion Of The Single-Cell Analysis Transcriptomics Market?
Major companies operating in the single cell analysis transcriptomics market are concentrating on developing innovative products, including single cell RNA sequencing kits, to streamline workflows and facilitate deeper insights into cellular heterogeneity. A single cell RNA sequencing kit serves as a specialized tool for isolating and analyzing gene expression at the individual cell level. It empowers researchers to uncover cellular diversity and gain understanding into complex biological processes. For instance, in January 2024, Scale Biosciences, a US-based biotechnology company specializing in single cell solutions, released the Single Cell RNA Kit v1.1-Extended Throughput, which allows for processing up to 500,000 cells per run through an instrument-free workflow. This new offering significantly enhances scaling, multiplexing, and cost efficiency in transcriptomic studies.
Which Major Firms Influence Developments In The Single-Cell Analysis Transcriptomics Market?
Major companies operating in the single-cell analysis transcriptomics market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., CYTENA GmbH, Fluent BioSciences
Read the full single-cell analysis transcriptomics market report here:
Which Region Is Projected To Dominate The Single-Cell Analysis Transcriptomics Market During The Forecast Period?
North America was the largest region in the single-cell analysis transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Single-Cell Analysis Transcriptomics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24400&type=smp
Browse Through More Reports Similar to the Global Single-Cell Analysis Transcriptomics Market 2026, By The Business Research Company
Single Cell Analysis Market 2026
https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market
Single Cell Omics Market Report 2026
https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report
Rna Analysis Transcriptomics Market Report 2026
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model